Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Caterina Marchio'"'
Autor:
Fabio Conforti, Laura Pala, Eleonora Pagan, Elena Guerini Rocco, Vincenzo Bagnardi, Emilia Montagna, Giulia Peruzzotti, Tommaso De Pas, Caterina Fumagalli, Silvana Pileggi, Chiara Pesenti, Sergio Marchini, Giovanni Corso, Caterina Marchio’, Anna Sapino, Rossella Graffeo, Laetitia Collet, Philippe Aftimos, Christos Sotiriou, Martine Piccart, Richard D. Gelber, Giuseppe Viale, Marco Colleoni, Aron Goldhirsch
Publikováno v:
Breast, Vol 59, Iss , Pp 94-101 (2021)
Background: We report here for the first time, a comprehensive characterization of biological and clinical features of early-stage triple negative Invasive Lobular Carcinomas(TN-ILCs) Methods: We analyzed all consecutive patients with early-stage TN-
Externí odkaz:
https://doaj.org/article/0e41cdfb84f743128a8f6f2c40685bb2
Autor:
Ning Zhang, Michele Simonetti, Luuk Harbers, Thomas Helleday, Vassilis Roukos, Caterina Marchio, Magda Bienko, Nicola Crosetto
Chromosomal instability and copy number alterations (CNAs) are pervasive in human cancers. However, the exact timing and mechanism of CNA formation during carcinogenesis remain poorly understood. Here, we describe scCUTseq, an agile and robust workfl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::23da6786adef7fa5c5dcf94ce5b7470f
https://doi.org/10.21203/rs.3.pex-1602/v1
https://doi.org/10.21203/rs.3.pex-1602/v1
Autor:
Christine Desmedt, Christos Sotiriou, Denis Larsimont, Giancarlo Pruneri, Anne Vincent-Salomon, Diether Lambrechts, Elia Biganzoli, Roberto Salgado, Gert van den Eynden, Christine Galant, Odette Mariani, François Bertucci, Florian Clatot, Caterina Marchio, Bram Boeckx, Julien Pingitore, Françoise Rothé, David Venet, Samira Majjaj, François Richard
Supplementary Tables
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1dcc6c0b6220b9d455da179bfd07e6c8
https://doi.org/10.1158/1078-0432.22476234.v1
https://doi.org/10.1158/1078-0432.22476234.v1
Autor:
Christine Desmedt, Christos Sotiriou, Denis Larsimont, Giancarlo Pruneri, Anne Vincent-Salomon, Diether Lambrechts, Elia Biganzoli, Roberto Salgado, Gert van den Eynden, Christine Galant, Odette Mariani, François Bertucci, Florian Clatot, Caterina Marchio, Bram Boeckx, Julien Pingitore, Françoise Rothé, David Venet, Samira Majjaj, François Richard
Supplementary Data tracked changes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4837a1752069ec4eb10362285adad9eb
https://doi.org/10.1158/1078-0432.22476240.v1
https://doi.org/10.1158/1078-0432.22476240.v1
Autor:
Christine Desmedt, Christos Sotiriou, Denis Larsimont, Giancarlo Pruneri, Anne Vincent-Salomon, Diether Lambrechts, Elia Biganzoli, Roberto Salgado, Gert van den Eynden, Christine Galant, Odette Mariani, François Bertucci, Florian Clatot, Caterina Marchio, Bram Boeckx, Julien Pingitore, Françoise Rothé, David Venet, Samira Majjaj, François Richard
Purpose:Invasive lobular carcinoma (ILC) represents the second most common histologic breast cancer subtype after invasive ductal carcinoma (IDC). While primary ILC has been extensively studied, metastatic ILC has been poorly characterized at the gen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47217f5a6242fb72b0496ebfc7fc7a15
https://doi.org/10.1158/1078-0432.c.6529344
https://doi.org/10.1158/1078-0432.c.6529344
Autor:
Alan Ashworth, Jorge S. Reis-Filho, Andrew Tutt, Anita Grigoriadis, Cheryl Gillett, Alan Mackay, Elizabeth Iorns, Caterina Marchio, Rachael Natrajan, Maria A. Lopez-Garcia, Felipe Geyer, Maryou Lambros, Rachel Sharpe, Alex Pearson, Nicholas Turner
Supplementary Figures 1-7 from FGFR1 Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18ece402049966356de70bc4333808d1
https://doi.org/10.1158/0008-5472.22385883.v1
https://doi.org/10.1158/0008-5472.22385883.v1
Autor:
Alan Ashworth, Jorge S. Reis-Filho, Andrew Tutt, Anita Grigoriadis, Cheryl Gillett, Alan Mackay, Elizabeth Iorns, Caterina Marchio, Rachael Natrajan, Maria A. Lopez-Garcia, Felipe Geyer, Maryou Lambros, Rachel Sharpe, Alex Pearson, Nicholas Turner
Supplementary Methods, Figure Legends 1-7 from FGFR1 Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b45c4a70081fec7a1d77a03fe8665be
https://doi.org/10.1158/0008-5472.22385880.v1
https://doi.org/10.1158/0008-5472.22385880.v1
Autor:
Danai Fimereli, David Venet, Mattia Rediti, Bram Boeckx, Marion Maetens, Samira Majjaj, Ghizlane Rouas, Caterina Marchio, Francois Bertucci, Odette Mariani, Maria Capra, Giuseppina Bonizzi, Federica Contaldo, Christine Galant, Gert Van den Eynden, Roberto Salgado, Elia Biganzoli, Anne Vincent-Salomon, Giancarlo Pruneri, Denis Larsimont, Diether Lambrechts, Christine Desmedt, David N. Brown, Françoise Rothé, Christos Sotiriou
Publikováno v:
EBIOMEDICINE
EBIOMEDICINE, 2022, 82, ⟨10.1016/j.ebiom.2022.104169⟩
EBIOMEDICINE, 2022, 82, ⟨10.1016/j.ebiom.2022.104169⟩
BACKGROUND: Late distant recurrence is a challenge for the treatment of invasive lobular carcinoma (ILC) of the breast. Despite in-depth characterisation of primary ILC, the molecular landscape of metastatic ILC is still only partially understood. ME
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a0ae5bc45d5dc2d4e355d7a326fd263
https://hal-amu.archives-ouvertes.fr/hal-04084988
https://hal-amu.archives-ouvertes.fr/hal-04084988
Autor:
Enrico Berrino, Maria Costanza Aquilano, Emanuele Valtorta, Vito Amodio, Giovanni Germano, Marco Gusmini, Ivana Sarotto, Anna Sapino, Silvia Marsoni, Andrea Sartore-Bianchi, Alberto Bardelli, Salvatore Siena, Emanuela Bonoldi, Caterina Marchio
Publikováno v:
Cancer Research. 82:5419-5419
Introduction: Mismatch repair (MMR) protein expression in colorectal cancer (CRC) is usually homogeneously retained or lost. However, rare CRC lesions may show a heterogeneous pattern of MMR protein expression. We aimed to evaluate the molecular effe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dea5e39abe5020849dc8c2fb723c7500
https://doi.org/10.1158/1538-7445.am2022-5419
https://doi.org/10.1158/1538-7445.am2022-5419
Autor:
Enrico Berrino, Laura Annaratone, Ivana Sarotto, Maria Cecilia Zecchillo, Laura Casorzo, Riccardo Ponzone, Filippo Montemurro, Anna Sapino, Caterina Marchio
Publikováno v:
Cancer Research. 82:5418-5418
Introduction & Purpose: “HER2low breast cancer” is an operational term identifying breast carcinomas (BCs) displaying a HER2 score 1+ or score 2+ in immunohistochemistry (IHC) and lacking HER2 amplification. This paradigm shift in HER2 assessment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4277f3ba8643c396f0aecf0b5a25dacd
https://doi.org/10.1158/1538-7445.am2022-5418
https://doi.org/10.1158/1538-7445.am2022-5418